International Clinical Trial: Feasibility of an Exercise Prehabilitation Program for adults with lymphoma planned to receive Chimeric Antigen Receptor (CAR) T-cell therapy (CAR-T Therapy)

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ACTRN12626000478314) titled 'Feasibility of an Exercise Prehabilitation Program for adults with lymphoma planned to receive Chimeric Antigen Receptor (CAR) T-cell therapy (CAR-T Therapy)' on April 17.

Study Type: Interventional

Study Design: Purpose: Prevention Allocation: Non-randomised trial Masking: Open (masking not used) Assignment: Single group

Primary Sponsor: Baker Heart and Diabetes Institute

Condition: Haematological Cancer Lymphoma Lymphoma (non Hodgkin's lymphoma) Haematological Cancer Lymphoma Lymphoma (non Hodgkin's lymphoma) Cancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma

Intervention: The exerci...